Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 – a prospective study

INTRODUCTION: Trastuzumab, a recombinant humanized monoclonal antibody, is targeted against the external domain of the human epidermal growth factor receptor type 2 (HER2). It improves efficacy of HER2-positive breast cancer treatment. The authors present their experience with patients (pts) treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Piotrowski, Grzegorz, Gawor, Rafał, Stasiak, Arkadiusz, Gawor, Zenon, Potemski, Piotr, Banach, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361034/
https://www.ncbi.nlm.nih.gov/pubmed/22661994
http://dx.doi.org/10.5114/aoms.2012.28549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361034/
https://www.ncbi.nlm.nih.gov/pubmed/22661994
http://dx.doi.org/10.5114/aoms.2012.28549

Ejemplares similares